AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33393275 — intervention group
Group type: COMPARATOR
Intervention: AMB and Control (No AMB)
Number of subjects: 18
Study 35124649 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training (CCT) with GRADIOR
Number of subjects: 0
Study 35124649 — intervention group
Group type: COMPARATOR
Intervention: Routine daily care (Control Group)
Number of subjects: 0
Study 33719708 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute scripted introduction to AD forms (grade 7 reading level)
Number of subjects: 529
Study 33719708 — intervention group
Group type: COMPARATOR
Intervention: Handing blank AD forms without explanation (Control)
Number of subjects: 529
Study 35064366 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg) at 8 AM, 1 PM, and placebo at 8 PM
Number of subjects: 70
Study 35064366 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (400 mg) at 8 AM, 1 PM, and 8 PM (Control)
Number of subjects: 70
Study 34085541 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing loss assessment in patients with type 2 diabetes
Number of subjects: 157
Study 34085541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorineural hearing loss assessment
Number of subjects: 157
Study 34085541 — intervention group
Group type: EXPERIMENTAL
Intervention: Disabling hearing loss assessment
Number of subjects: 157
Study 34085541 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of hearing loss with glycemic control
Number of subjects: 157
Study 34085541 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with hearing loss
Number of subjects: 157
Study 34143404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based (DB) intervention
Number of subjects: 74
Study 34143404 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control (AOC)
Number of subjects: 74
Study 33789474 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings
Number of subjects: 462
Study 33789474 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (iNPWT)
Number of subjects: 462
Study 35720911 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 36
Study 35720911 — intervention group
Group type: COMPARATOR
Intervention: Control (Obese group)
Number of subjects: 36
Study 34542190 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc combination
Number of subjects: 0
Study 35272949 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Carotid Endarterectomy (CEA)
Number of subjects: 3120
Study 35272949 — intervention group
Group type: COMPARATOR
Intervention: Deferral of Carotid Endarterectomy (no intervention unless triggered)
Number of subjects: 3120
Study 37919141 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (Comirnaty®, 30 µg)
Number of subjects: 53
Study 37919141 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (Spikevax®, 100 µg)
Number of subjects: 53
Study 33671217 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional (GC)
Number of subjects: 90
Study 33671217 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating (GA)
Number of subjects: 90
Study 33671217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed multi-bracket low friction (GS)
Number of subjects: 90
Study 32825189 — intervention group
Group type: EXPERIMENTAL
Intervention: Various dietary patterns (specific diets not detailed)
Number of subjects: 0
Study 32825189 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical and alternative methods of treatment
Number of subjects: 0
Study 32825189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary interventions
Number of subjects: 0
Study 36016478 — intervention group
Group type: EXPERIMENTAL
Intervention: Local ibuprofen (Odontocide)
Number of subjects: 90
Study 36016478 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic ibuprofen (Ultracal + 200 mg ibuprofen)
Number of subjects: 90
Study 36016478 — intervention group
Group type: COMPARATOR
Intervention: Control group (Ultracal)
Number of subjects: 90
Study 36164019 — intervention group
Group type: EXPERIMENTAL
Intervention: P1101 (ropeginterferon Alfa-2b) administered subcutaneously every 2 weeks at starting dose of 250 mcg (Week 0), 350 mcg (Week 2), and target dose of 500 mcg (Week 4) for the remainder of the treatment period.
Number of subjects: 101
Study 36164019 — intervention group
Group type: COMPARATOR
Intervention: Anagrelide (ANA) dosed according to local country label.
Number of subjects: 101
Study 34058870 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted UKA
Number of subjects: 130
Study 34058870 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual UKA
Number of subjects: 130
Study 36348617 — intervention group
Group type: EXPERIMENTAL
Intervention: Clade C regimen (adenovirus 26-based HIV-1 vaccine encoding 2 mosaic Gag and Pol, and 2 mosaic Env proteins plus adjuvanted clade C gp140)
Number of subjects: 155
Study 36348617 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent protein regimen (clade C regimen plus mosaic gp140)
Number of subjects: 155
Study 36348617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 33635500 — intervention group
Group type: EXPERIMENTAL
Intervention: ICPA 2043
Number of subjects: 2
Study 33635500 — intervention group
Group type: COMPARATOR
Intervention: ICPB 2043
Number of subjects: 2
Study 33635500 — intervention group
Group type: EXPERIMENTAL
Intervention: qRT‐PCR assay
Number of subjects: 2
Study 32859522 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-min algorithm
Number of subjects: 19
Study 32859522 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-min algorithm
Number of subjects: 19
Study 32859522 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-min algorithm
Number of subjects: 19
Study 32859522 — intervention group
Group type: EXPERIMENTAL
Intervention: 150-min algorithm
Number of subjects: 19
Study 32859522 — intervention group
Group type: EXPERIMENTAL
Intervention: 180-min algorithm
Number of subjects: 19
Study 32859522 — intervention group
Group type: COMPARATOR
Intervention: Self-report
Number of subjects: 19
Study 35906532 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiomics model using perivascular fat CT radiomics features and clinical risk factors
Number of subjects: 200
Study 33135182 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg, once-yearly for 2 years)
Number of subjects: 656
Study 33135182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656
Study 32338233 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial pulsed electromagnetic fields
Number of subjects: 84
Study 32338233 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate immediate release
Number of subjects: 84
Study 34897793 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix-adjusted estimating equations for the correlation parameters with a bias-corrected sandwich variance estimator
Number of subjects: 0
Study 34897793 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equations approach using model-based variance
Number of subjects: 0
Study 34897793 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equations approach using sandwich variance with independence working correlation matrix
Number of subjects: 0
Study 33612647 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 16
Study 33612647 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Fat Percentage
Number of subjects: 16
Study 35013548 — intervention group
Group type: EXPERIMENTAL
Intervention: Modest systemic hypothermia (33 C) for 48 hours
Number of subjects: 50
Study 35013548 — intervention group
Group type: COMPARATOR
Intervention: Standard of care medical treatment
Number of subjects: 50
Study 34323437 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous epidural lysis of adhesions
Number of subjects: 90
Study 34323437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32245908 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocuff Vision‐assisted BowelScope (EAB)
Number of subjects: 3222
Study 32245908 — intervention group
Group type: COMPARATOR
Intervention: Standard BowelScope (SB)
Number of subjects: 3222
Study 36307956 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-protein diet with 25 g beef/d (B25, n=45)
Number of subjects: 80
Study 36307956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet with 150 g beef/d (B150, n=35)
Number of subjects: 80
Study 34292206 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 24
Study 34292206 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 24
Study 34292206 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-guided acupuncture imagery treatment (VGAIT)
Number of subjects: 24
Study 34292206 — intervention group
Group type: COMPARATOR
Intervention: VGAIT control
Number of subjects: 24
Study 33156099 — intervention group
Group type: EXPERIMENTAL
Intervention: Engerix-B double dose
Number of subjects: 173
Study 33156099 — intervention group
Group type: EXPERIMENTAL
Intervention: Fendrix single dose
Number of subjects: 173
Study 33156099 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 173
Study 35120546 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training with a multi-joint functional exoskeleton
Number of subjects: 26
Study 35120546 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy program
Number of subjects: 26
Study 33602603 — intervention group
Group type: EXPERIMENTAL
Intervention: Biotène Moisturizing Spray (3 sprays)
Number of subjects: 25
Study 33602603 — intervention group
Group type: COMPARATOR
Intervention: Water spray (active control)
Number of subjects: 25
Study 32179181 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling arm (vaginal self-sampling kit)
Number of subjects: 88
Study 32179181 — intervention group
Group type: COMPARATOR
Intervention: Control arm (recommendations to have a Pap smear taken)
Number of subjects: 88
Study 34231204 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular approach
Number of subjects: 401
Study 34231204 — intervention group
Group type: COMPARATOR
Intervention: Infraclavicular approach
Number of subjects: 401
Study 34310874 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium electroporation (CaEP)
Number of subjects: 3486
Study 34310874 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) with intravenous and intratumoral administration of bleomycin
Number of subjects: 3486
Study 34310874 — intervention group
Group type: COMPARATOR
Intervention: Reversible and irreversible electroporation (control arm - group A)
Number of subjects: 3486
Study 34310874 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS), body weight, pain level, and levels of biomarkers such as Ca 19-9
Number of subjects: 3486
Study 33027362 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (antibiotic group)
Number of subjects: 124
Study 33027362 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 124
Study 35822425 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor (ACEi)
Number of subjects: 48
Study 35822425 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 48
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics
Number of subjects: 149
Study 32519208 — intervention group
Group type: COMPARATOR
Intervention: Second-generation antipsychotics
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors' assessments
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: PSP Scale
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (SF-36)
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of disease (PANSS)
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of sexual activities
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being under treatment
Number of subjects: 149
Study 32519208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive changes
Number of subjects: 149
Study 32361220 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-ultrasound monitoring
Number of subjects: 88
Study 32361220 — intervention group
Group type: COMPARATOR
Intervention: Control group (CXR and clinical findings)
Number of subjects: 88
Study 35202468 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem Control‐IQ (CIQ) hybrid closed loop (HCL) system
Number of subjects: 49
Study 33487503 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen protein hydrolysate + milk protein (CP+MP)
Number of subjects: 8
Study 33487503 — intervention group
Group type: COMPARATOR
Intervention: Milk protein (MP)
Number of subjects: 8
Study 36170254 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress sample (post-task)
Number of subjects: 36
Study 36170254 — intervention group
Group type: COMPARATOR
Intervention: Baseline sample (pre-task)
Number of subjects: 36
Study 34495579 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of fresh table grape per kg of body weight for 21 days
Number of subjects: 40
Study 34495579 — intervention group
Group type: COMPARATOR
Intervention: Dietary recommendations only (Control)
Number of subjects: 40
Study 37735383 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge (G1)
Number of subjects: 72
Study 33720637 — intervention group
Group type: EXPERIMENTAL
Intervention: Donanemab (700 mg for the first three doses and 1400 mg thereafter)
Number of subjects: 257
Study 33720637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 33720637 — intervention group
Group type: EXPERIMENTAL
Intervention: Donanemab
Number of subjects: 257
Study 35241182 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive therapy
Number of subjects: 30
Study 35241182 — intervention group
Group type: COMPARATOR
Intervention: General form of CBT treatment
Number of subjects: 30
Study 33814546 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 95
Study 33814546 — intervention group
Group type: COMPARATOR
Intervention: Other antipsychotics
Number of subjects: 95
Study 34251882 — intervention group
Group type: EXPERIMENTAL
Intervention: Early weightbearing (allowed weightbearing at 2 weeks postoperatively)
Number of subjects: 194
Study 34251882 — intervention group
Group type: EXPERIMENTAL
Intervention: Early weightbearing
Number of subjects: 194
Study 34251882 — intervention group
Group type: COMPARATOR
Intervention: Nonweightbearing (not allowed weightbearing until 6 weeks postoperatively)
Number of subjects: 194
Study 32116155 — intervention group
Group type: EXPERIMENTAL
Intervention: NA1
Number of subjects: 150
Study 32116155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 36453313 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival MMC injection at the end of trabeculectomy
Number of subjects: 40
Study 36453313 — intervention group
Group type: COMPARATOR
Intervention: IntraTenon MMC injection before the initial conjunctival incision
Number of subjects: 40
Study 34247604 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive Scheme intervention (conditional economic incentives and motivational interviewing)
Number of subjects: 0
Study 34247604 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study 34624174 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC tablets of macitentan/tadalafil (10/40 mg)
Number of subjects: 62
Study 35151971 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMT) 25 mg every night
Number of subjects: 80
Study 35151971 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (VLF) 37.5 mg daily
Number of subjects: 80
Study 35151971 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (AMT)
Number of subjects: 80
Study 35151971 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine (VLF)
Number of subjects: 80
Study 33630912 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT)
Number of subjects: 101
Study 33630912 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forests (RF) machine learning algorithm
Number of subjects: 101
Study 33630912 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression (LR) analysis
Number of subjects: 101
Study 33630912 — intervention group
Group type: EXPERIMENTAL
Intervention: Retina fraction dose
Number of subjects: 101
Study 33630912 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 101
Study 32652491 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of mental fatigue (n = 30)
Number of subjects: 55
Study 32652491 — intervention group
Group type: COMPARATOR
Intervention: Low-moderate levels of mental fatigue (n = 25)
Number of subjects: 55
Study 32652491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental fatigue
Number of subjects: 55
Study 32652491 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical thickness
Number of subjects: 55
Study 35665493 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback assisted relaxation training (BART)
Number of subjects: 38
Study 35665493 — intervention group
Group type: COMPARATOR
Intervention: Distraction therapy
Number of subjects: 38
Study 32053400 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg position (TP)
Number of subjects: 14
Study 32053400 — intervention group
Group type: COMPARATOR
Intervention: Increased airway pressure (Paw) at 15, 20, 25, and 30 cmH2O
Number of subjects: 14
Study 32053400 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg position (TP) during increasing Paw
Number of subjects: 14
Study 32053400 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-liver resection
Number of subjects: 14
Study 36309152 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface guidance using AlignRT (procedure B)
Number of subjects: 25
Study 36309152 — intervention group
Group type: COMPARATOR
Intervention: Skin marks and tattoos (procedure A)
Number of subjects: 25
Study 33084205 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural bovine bone mineral covered with resorbable native collagen membrane (BBM/CM)
Number of subjects: 40
Study 33084205 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF alone
Number of subjects: 40
Study 33084205 — intervention group
Group type: COMPARATOR
Intervention: Control (spontaneous healing)
Number of subjects: 40
Study 32171050 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound care knowledge education
Number of subjects: 36
Study 32171050 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound care skills training
Number of subjects: 36
Study 34862248 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy (200 mg IV every 3 weeks)
Number of subjects: 76
Study 34862248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Acalabrutinib (100 mg orally twice daily)
Number of subjects: 76
Study 34862248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Acalabrutinib
Number of subjects: 76
Study 34862248 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy
Number of subjects: 76
Study 33297451 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk exercises on unstable surfaces
Number of subjects: 35
Study 33297451 — intervention group
Group type: COMPARATOR
Intervention: Upper limb exercises (control group)
Number of subjects: 35
Study 33555696 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve block and residual pain managed with opioids
Number of subjects: 60
Study 33555696 — intervention group
Group type: COMPARATOR
Intervention: Opioids alone
Number of subjects: 60
Study 32826406 — intervention group
Group type: EXPERIMENTAL
Intervention: Danish Whiplash Group Risk Assessment Score (DWGRAS)
Number of subjects: 927
Study 34592684 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate (N=13)
Number of subjects: 39
Study 34592684 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg caffeine (N=14)
Number of subjects: 39
Study 34592684 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil (N=12)
Number of subjects: 39
Study 34592684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32128549 — intervention group
Group type: EXPERIMENTAL
Intervention: IASTM using Graston instruments
Number of subjects: 16
Study 32128549 — intervention group
Group type: EXPERIMENTAL
Intervention: Roller massage stick
Number of subjects: 16
Study 35617098 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 126
Study 35617098 — intervention group
Group type: COMPARATOR
Intervention: No nutrition education
Number of subjects: 126
Study 34960013 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-based (CB) intervention
Number of subjects: 22
Study 34960013 — intervention group
Group type: COMPARATOR
Intervention: Survivor-only (SO) intervention
Number of subjects: 22
Study 34960013 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-based (CB) intervention (spouses)
Number of subjects: 22
Study 34960013 — intervention group
Group type: COMPARATOR
Intervention: Survivor-only (SO) intervention (spouses)
Number of subjects: 22
Study 34960013 — intervention group
Group type: COMPARATOR
Intervention: Couples-based (CB) spouses vs Survivor-only (SO) spouses
Number of subjects: 22
Study 34318542 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephone support with regular text messages and phone calls
Number of subjects: 77
Study 34318542 — intervention group
Group type: COMPARATOR
Intervention: Usual hypertension care
Number of subjects: 77
Study 34304669 — intervention group
Group type: EXPERIMENTAL
Intervention: Late preeclampsia group
Number of subjects: 160
Study 34304669 — intervention group
Group type: COMPARATOR
Intervention: Healthy pregnant women group
Number of subjects: 160
Study 32504715 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine rehabilitation group (SRG)
Number of subjects: 60
Study 32504715 — intervention group
Group type: EXPERIMENTAL
Intervention: Erect rehabilitation group (ERG)
Number of subjects: 60
Study 32504715 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SRG and ERG)
Number of subjects: 60
Study 36134902 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneously q6 months)
Number of subjects: 30